Free Trial

CareDx (CDNA) Competitors

CareDx logo
$19.20 -0.30 (-1.51%)
Closing price 07/3/2025 02:58 PM Eastern
Extended Trading
$19.26 +0.07 (+0.34%)
As of 07/3/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CDNA vs. RDNT, BTSG, SHC, CON, PRVA, SGRY, WGS, VCYT, ADUS, and PACS

Should you be buying CareDx stock or one of its competitors? The main competitors of CareDx include RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Concentra Group Holdings Parent (CON), Privia Health Group (PRVA), Surgery Partners (SGRY), GeneDx (WGS), Veracyte (VCYT), Addus HomeCare (ADUS), and PACS Group (PACS). These companies are all part of the "healthcare" industry.

CareDx vs. Its Competitors

CareDx (NASDAQ:CDNA) and RadNet (NASDAQ:RDNT) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, media sentiment, risk, dividends, profitability, analyst recommendations, institutional ownership and valuation.

CareDx currently has a consensus target price of $30.33, indicating a potential upside of 58.03%. RadNet has a consensus target price of $69.60, indicating a potential upside of 23.93%. Given CareDx's higher probable upside, research analysts clearly believe CareDx is more favorable than RadNet.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CareDx
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.67
RadNet
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
3 Strong Buy rating(s)
3.50

77.9% of RadNet shares are owned by institutional investors. 4.4% of CareDx shares are owned by company insiders. Comparatively, 5.6% of RadNet shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, CareDx had 2 more articles in the media than RadNet. MarketBeat recorded 7 mentions for CareDx and 5 mentions for RadNet. CareDx's average media sentiment score of 1.01 beat RadNet's score of 0.80 indicating that CareDx is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CareDx
4 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
RadNet
2 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

CareDx has a beta of 2.19, indicating that its share price is 119% more volatile than the S&P 500. Comparatively, RadNet has a beta of 1.41, indicating that its share price is 41% more volatile than the S&P 500.

CareDx has higher earnings, but lower revenue than RadNet. RadNet is trading at a lower price-to-earnings ratio than CareDx, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CareDx$333.79M3.20$52.55M$1.1516.69
RadNet$1.83B2.30$2.79M-$0.43-130.60

CareDx has a net margin of 19.79% compared to RadNet's net margin of -1.73%. CareDx's return on equity of 21.16% beat RadNet's return on equity.

Company Net Margins Return on Equity Return on Assets
CareDx19.79% 21.16% 14.25%
RadNet -1.73%1.41%0.48%

Summary

CareDx beats RadNet on 12 of the 17 factors compared between the two stocks.

Get CareDx News Delivered to You Automatically

Sign up to receive the latest news and ratings for CDNA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CDNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CDNA vs. The Competition

MetricCareDxMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$1.07B$7.31B$5.53B$9.04B
Dividend YieldN/A2.78%5.24%4.01%
P/E Ratio16.6927.9427.6420.25
Price / Sales3.2032.39416.59118.23
Price / Cash14.1522.0136.8958.07
Price / Book2.726.698.035.67
Net Income$52.55M$233.06M$3.18B$249.21M
7 Day Performance-0.18%3.33%2.92%3.28%
1 Month Performance2.32%3.72%3.72%5.55%
1 Year Performance23.60%37.40%35.14%21.08%

CareDx Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CDNA
CareDx
4.5242 of 5 stars
$19.20
-1.5%
$30.33
+58.0%
+28.9%$1.07B$333.79M16.69740News Coverage
Positive News
RDNT
RadNet
3.6726 of 5 stars
$54.87
-0.7%
$69.60
+26.8%
-5.2%$4.12B$1.83B-127.6011,021
BTSG
BrightSpring Health Services
1.6251 of 5 stars
$22.77
+2.2%
$24.90
+9.4%
+95.5%$4.00B$11.27B81.3235,000Analyst Upgrade
SHC
Sotera Health
2.9712 of 5 stars
$11.09
-2.6%
$15.80
+42.5%
+0.8%$3.15B$1.10B138.643,000
CON
Concentra Group Holdings Parent
2.5316 of 5 stars
$20.95
+1.0%
$28.50
+36.0%
N/A$2.69B$1.90B15.6311,250
PRVA
Privia Health Group
4.2547 of 5 stars
$21.61
-1.1%
$27.77
+28.5%
+30.4%$2.63B$1.74B180.101,140News Coverage
SGRY
Surgery Partners
2.6009 of 5 stars
$20.20
+4.7%
$33.56
+66.1%
-6.1%$2.59B$3.11B-13.2015,000
WGS
GeneDx
2.2055 of 5 stars
$79.71
+19.0%
$86.75
+8.8%
+227.2%$2.27B$305.45M-56.531,200Analyst Upgrade
Insider Trade
Gap Up
High Trading Volume
VCYT
Veracyte
3.6071 of 5 stars
$26.71
+1.2%
$40.90
+53.1%
+28.1%$2.09B$445.76M65.15790
ADUS
Addus HomeCare
4.9688 of 5 stars
$113.01
-0.7%
$142.57
+26.2%
-4.7%$2.08B$1.15B25.5149,703
PACS
PACS Group
2.7372 of 5 stars
$12.77
-3.1%
$34.29
+168.5%
-56.2%$1.95B$3.56B0.0032,433

Related Companies and Tools


This page (NASDAQ:CDNA) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners